CITIC Securities Analyst Suspended after Disclosing Drug Firm's Compensation Plan

(Beijing) – CITIC Securities has suspended an analyst who put information about Lizhu Medicine Group Holding Co. Ltd. on a messaging app's group chats.

Lizhu, a medicine company listed in Shenzhen, said it will halt trading of its shares on June 9 until it releases a plan on stock-based incentive compensation for its employees.

Zhang Mingfang, a top analyst in the medicine field at CITIC Securities, disclosed information about the compensation plan on June 6 via the messaging app WeChat. She put details about Lizhu's plan in multiple chat groups for investors and fund managers on June 6, screenshots of the messages show. She wrote that the information would be announced on June 10.